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Abstract. Cytokines play a critical role in the patho-
genesis of dengue hemorrhagic fever and have been used
as markers of severity disease. In this study we measured
serum levels of five cytokines in dengue infected
children and correlate their levels with shock and
complicated forms such as myocarditis, hepatitis or
bleeding.
Methods: 30 patients who met WHO criteria for den-
gue hemorrhagic fever (DHF) were enrolled and
classified into two groups: group one without shock
(grade I and II) and group two with shock (grade III and
IV). Serum levels of TNFα, IL-6, IL-10, IL-4 and IFNγ
were measured by ELISA at first day of defervescence
and were compared with serum levels of 28 healthy
children.
Results: from 30 patients, 9 were assigned to group
number one (median age 67 months) and 21 to group
two (median age 42 months). Statistical differences were
found between dengue infected patients and controls:
controls IL-6 (5.2 pg/ml), group 1 (485 pg/ml) (p=0.002)
and group 2 (190 pg/ml) (p=0.001); TNFα, control
group (70 pg/ml), group 1 (586.7 pg/ml) (p=0.021) and
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group 2 (320.7 pg/ml) (p<0.001) and for IFNγ, control
group (12.3 pg/ml), group 2 (27.5 pg/ml) (p=0.019).
However, we could not find correlation between
cytokines and shock or complicated forms of illness.
IL-4 and IL-10 did not show differences between any
tested groups.
Conclusion: IL-6, TNFα and IFNγ are elevated in
children with dengue hemorrhagic fever, but there was
not correlation with severe forms of shock.
Key words: Dengue, Dengue hemorrhagic fever (DHF),
shock dengue syndrome (SDS), Cytokines.
Resumen. Las citoquinas juegan un papel crítico en la
patogénesis de la fiebre dengue hemorrágico (FDH) y
han sido usadas como marcadores de severidad. En
este estudio se midieron los niveles de cinco citoquinas
en niños infectados con dengue y se correlacionaron
con el choque y las formas complicadas tales como mio-
carditis, hepatitis o sangrado.
Método: 30 pacientes que cumplían los criterios de la
OMS para FDH fueron incluidos y clasificados en dos
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grupos: grupo 1, sin choque (grado I y II) y grupo 2, con
choque (grado III y IV). Niveles séricos de TNFα, IL-6,
IL-10. IL-4 e IFN γ fueron medidos por ELISA en el pri-
mer día de la defervescencia y comparados con los res-
pectivos niveles de 28 niños sanos.
Resultados: de los 30 pacientes, 9 fueron clasificados
en el grupo número 1 (media de edad de 67 meses) y 21
en el grupo 2 (media de la edad 42 meses). Diferencias
estadísticamente significativas fueron encontradas en-
tre niños infectados con dengue y controles sanos: sa-
nos IL-6 (5,2 pg/ml), grupo 1 (485 pg/ml) (p = 0,002) y
grupo 2 (190 pg/ml) (p = 0,001); TNFα, grupo control
(70 pg/ml), grupo 1 (586,7 pg/ml) (p = 0,021) y grupo 2
(320,7 pg/ml) (p < 0,001) y para IFNγ, grupo control
(12,3 pg/ml), grupo 2 (27,5 pg/ml) (p = 0,019). Sin em-
bargo, no se encontró correlación entre las citoquinas y
el choque o las otras formas evaluadas. IL-4 e IL-10 no
fueron diferentes en ninguno de los grupos analizados.
Conclusión: IL-6, TNFα e IFNγ están elevadas en niños
con FDH, pero no hubo correlación con las formas se-
veras de choque.
Palabras clave: dengue, fiebre dengue hemorrágico
(DH), síndrome de choque por dengue (SSD), citoquinas.
INTRODUCTION
Dengue hemorrhagic fever (DHF) has emerged
as the most important arbovirus disease in man
in the last three decades. It has been estimated
that about 50 million cases of DF occur every
year with about 250,000 to 500,000 cases of
DHF(1). In 2001 there was an unprecedented glo-
bal dengue epidemic activity in American
countries, the Pacific islands and Asia. During
2002, more than 30 Latin American countries
reported over 10,000,000 DF cases with large
number of DHF cases(2). In Colombia global
incidence rate is about 13 cases for 100,000
habitants but in some regions such as Santander
or Huila this rate is higher than 60 cases for
100,000 and has become a leading cause of
hospitalization and death among children(3).
Dengue virus (DV) infection has a spectral
presentation from asymptomatic forms to den-
gue fever (DF) and dengue hemorrhagic fever
(DHF) with life threatening situations of shock,
bleeding or more recently described complicated
atypical forms like hepatitis, encephalitis,
myocarditis(4-6).
Studies have shown the cytokines as a pivotal
piece in the pathogenesis of dengue hemorrhagic
fever that reflects an imbalance between T helper
1 (Th1) and Th2 response. Thus, an early Th1
response has been characterized with a
production of IFNγ and IL-2 which mediate
cellular activation needed for viral clearance and
later a Th2 response with IL-4, IL-5, IL-6, IL-10
and IL-13 release which are responsible for pro
inflammatory effect with endothelium and
homeostatic alterations leading to shock
and bleeding forms(7). Recently, others cytokines
such as IL8(8), IL-1Ra(9), IL-12(10), hCTF(7), MIF(11)
has been obtained from another cells such as
endothelium, neutrophil, dendritic cells and
hepatocytes when these are infected by dengue
virus, which gives us an idea of complexity of
cytokine role in dengue hemorrhagic fever.
However, exist a variation of cytokines pattern
according to dengue virus serotype and HLA
polymorphism(12) that could explain individual
patterns of cytokine in each population and why
some regions have more tendency to dengue
hemorrhagic fever with severe and complicated
forms. In this study we will determine cytokines
profile in a population of children from Neiva,




This study included thirty patients under 13
years old who were admitted to Pediatric
Department of Hospital Universitario de Neiva
between june 2004 to June 2005. Entry criteria
were clinical diagnosis of DHF using WHO
criteria before the results of serological studies
were known and severity of illness was graded
according to the presence of shock into two
groups: group one without shock and group
two with shock. 28 healthy children in the out
patient department served as a control group.
Epidemiological and clinical dates were recorded
at time of day sixth when measure of cytokines
were made.
The study was approved by the Medical ethics
Committee of Medicine program from Universi-
dad Surcolombiana and by the ethics committee
of the Hospital Universitario de Neiva. Informed
consent was obtained from the parent of each
patient included in the study.
Laboratory testing
Blood sample was obtained at first day of
defervescence (+2 day of disease). Cytokines
TNFα, IL-6, IL-10, IL-4 and IFNγ were measured
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with an ELISA technique (Anogen, Ontario, CA)
according to the manufacturer’s instructions.
These cytokines were measured also in healthy
patients as control. The limit detection of every
cytokine was: IL-4 (4.3pg/mL), IL-6 (1.7pg/mL),
IL-10 (2pg/mL), TNFα (4pg/mL) and IFNγ
(7.5pg/mL). Standards were included in each
assay and the curve was used for estimation of
cytokine concentration (in pg/mL) by regression
analysis. Ig M for dengue virus was made using
ELISA technique as well (PanBio).
Coagulation test (prothrombine time, partial
thromboplastine time and platelets count), liver
function test (alanine aminotransferase-ALT,
aspartate aminotransferase-AST) and electro-
cardiograph were made to determine liver,
haemostatic and myocardium involvement
respectively.
Date analysis
All data are presented as median and range.
Differences in levels of IL-6, TNFα, IL-10, IFNγ
and IL-4 between cases and controls as well as
between controls, shock and no shock patients
were analyzed by the Kruskal-Wallis follow by
Dunn´s multiple comparison test. P value of less
than 0.05 was considered to represent a signifi-
cant difference. All statistical calculations were
done using SPSS 6.0 and Graphpad prism 4.0
software.
RESULTS
From a total of thirty patients, nine (30%) were
classified in the group without shock and twenty
one (70%) in the group with shock from whom,
five patients had profound shock with narrow
of pulse pressure lesser than 20 mmHg.
The median age, gender distribution and signs
and symptoms in each group are presented in
Table 1. Forty three percent of patients included
were younger than 4 years old with a youngest
has 6 months and older has 12 years. We
observed that patients in the group with shock
were younger (median age 48 months) and
showed more symptoms compared to group
without shock (median age 74 months).
Patients has a median of fever 4.6 days because
we are reference hospital. Between clinical signs
hepatomegaly was a constant finding followed
by pleural effusion (median 30%) and bleeding
in a 60% of patients in both groups.
Between laboratory test, platelets count were under
50,000x mm3 in around 50% of patients and less
Table 1. Clinical characteristics.
Characteristics Group 1 Group 2N= 9 N= 21
Age median in months (range) 74 (6-128) 48 (7-120)
Gender Male/ Female 06-mar 10-nov
Fever days median (range) 4,2 (1-6) 4,7 (2-6)
Headache 23% n = 7 43% n = 13
Vomiting 23% n = 7 50% n = 15
Bleeding  (%) 15 26
Epistaxis n = 3 n = 5
Gyngivorhragie n = 1 n = 1
Melene n = 1 n = 3
Systolic pressure median in mm Hg (SD) 100 (90-112) 89 (80-106)
Hepatomegaly (cms) 2,4 cm 3,1 cm
Laboratory test
% Hemoconcentration-median (range) 8.4 (4.5-11.9) 24 (11-34)
Platelet count x103 (ul/mm3) median (range) 32.8 (11.1-46) 38.9 (10-56.1)
AST U/l median (range) 227 (45-456) 175 (89-546)
ALT U/l median (range) 81 (79-179) 127 (70-184)
Prothrombine time (sec) median (range) 15 (12-18) 20 (11-118)
Partial thromboplastine time (sec) median (range) 58 (40-63) 65 (41-124)
% Pleural Effusion index median (range) 10 (7-15) 30 (16-39)
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Based in clinical and laboratory findings were
identified: 11 (36.6%) cases of hepatitis, 8 (26.6%)
cases suggestive of myocarditis and 13 (43.3%)
cases of bleeding.
Pattern of cytokines in dengue infected
children
Serum levels of TNFα, IL-6, IFNγ, IL-10 and IL-4
in patients with dengue hemorrhagic fever in all
groups are summarized in Figure 1. P of Kruskal-
Wallis test were < 0.01 in all the cytokines
analyzed. We found statistically differences for
IL-6 between controls and group one (p = 0.001)
and group two (p = 0.001); for TNFα between
controls and group one (p = 0.001) and group
two (p< 0.001) and IFNγ between controls and
shock patients (p = 0.019). Of note, serum levels
of TNFα and IL-6 were higher in patients
without shock but there were not statistically
difference between shock and no shock groups.
of 20,000x mm3 in 20% of patients; prothrombine
time has a median of 20 sec with a higher value of
118” and partial thromboplastine time has a mean
value of 65” with a higher value of 124”.
Aminotransferase levels were higher for AST
with a median value of 403.1 U/l in both groups
(227 U/l group 1 and 175 U/l group 2) com-
pared to ALT levels of 171.5 U/l (81 u/l group 1
and 127 U/l group 2) with AST/ALT ratio of
2.3 as were described for hepatitis dengue.
Electrocardiograph was abnormal in 8 patients
with rhythm alteration and ST changes however
echocardiogram was not available in these
patients.
Despite clinical and laboratory test were more
abnormal in patients with shock we did not find
statistically differences between groups for any
of this variables.
Figure 1. Pattern of serum levels of cytokines in healthy controls, dengue infected children without or with
shock. Levels of cytokines were detected by ELISA six days after fever beginning. Lines represented the
median. Kruskal-Wallis P values are shown.
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IL-4 and IL-10 did not show statistical differences
between healthy and dengue infected patients
(Figure 1).
No correlation between levels of TNFα or IL-6
with a marker of Hepatic injury (AST) was found
(Figure 2A). On the other hand, bleeding
paraclinical signs (platelet number and PTT)
were not clearly associated with and IL-6, TNFα
and IL-10 levels as well.
Median days of stay was 6 and there were not
deaths.
DISCUSSION
DF and DHF is an endemic-epidemic disease in
Huila. Although there is a shift toward young
adults(1) severe forms of DHF with shock
continue to be more frequent in children as is
showed in this study almost under five years old;
symptoms such as vomiting, bleeding, abdominal
pain are still alarm signs in dengue hemorrhagic
Figure 2. Hepatitis and bleeding are not related with TNFα or IL-6 levels. (A). No correlation was found
between TNFα or IL-6 with AST (marker of hepatic injury) values (A) or bleeding sings (PTT and platelet
number) (B).
fever because they are correlated with plasma
leakage and shock.
In this study there was a higher incidence of
hepatitis, myocarditis and bleeding in patients
with shock thus, these complicated forms can
be considered such a markers of severity. The
liver involvement has been studied from asian
epidemics where patients showed necrosis and
hepatitis in focal and generalized forms with
apoptotic changes similar to findings in yellow
fever. There after, studies showed to hepatocytes
and Kuppfer cells such as target of the virus and
contribute to cytokines and mediators release
such as IL-6, C-reactive protein and secretory
phospholipase A2 (sPLA2) type II, which in turn
may worse inflammatory response(13) Clinical
studies have correlated severity with amino-
transferase levels, an increase more than 10 folds
normal value are considered such a marker of
severity. It is consistent with our results that show
high levels of aminotransferase specifically
aspartate aminotransferase levels (AST, mean
403 U/l).
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day, IFNγ appeared on the 2nd day with a peak
on the 3rd day, IL 10, IL5 start later on the 4th
day and IL-4 on the 6th day(27).
Nguyen et al. showed that infants with DHF/
DSS had levels of IFNγ in the acute-phase
significantly higher than those in samples from
healthy control (56.2 vs. 4.1 pg/ml) and were
increased on day 4 to day 6 after the onset of
fever and rapidly decreased on day 7 and during
the convalescent phase, similar results were
observed with TNFα levels which were elevated
on day 4 to day 7 after the onset of fever and
decreased on day 8 to day 19; IL-10 and IL-6
levels were also detected in the acute-phase but
a lesser degree, thus is observed a Th1 predo-
minant response in acute phase(25). Kurane et al.,
described T cell response in children with DHF/
DSS; they found IL-2 levels > 10 U/ml in 63%
(26/41) of patients during days 3-8 after onset
of fever and IFNγ was detected in 97% (34/35)
of the patients with DHF on days 3-8 (p < 0.001
on days 3-6 and p < 0.02 on days 7-8) Our
results presented in fig 1, shown a significant
elevated levels of serum IFNγ in shock group. This
cytokine is specially produced by T cells and it
will be consistent and indicate that T lym-
phocytes are activated in vivo during DHF(28).
In our study, cytokines measured at sixth day
showed important levels of IFNγ, TNFα and IL6
in DHF compared to controls but IL10 and IL4
levels were similar to healthy patients, which
reflect a predominant and persistent Th1
response in our patients. We could not find
correlation with severity and higher levels of
TNFα and IL-6 were seen in patients without
shock. In this regard, other studies have found
similar results. Kurane in the study mentioned
above, did not find significant differences in the
levels of sIL-2R, sCD4, sCD8, IL-2, and IFNγ
among grades I, II, and III of DHF. Analysis in
the Nguyen’s study, do not found statistical
differences in serum levels of IFNγ, TNFα, IL-10,
and IL-6 between patients with no shock DHF
and those with DSS, but a significantly higher
elevation of IL-6 was observed in patients who
died than in patients who survived the
infection.
Despite of these clinical correlation were not
conclusive, there are many studies which shown
individual correlation of cytokine and severity.
Elevated serum levels of TNFα and IL-6 as well
as their association with severity of the disease
and with DHF/DSS have been reported in
human dengue infection(29). One fatal case in Rio
Bleeding signs were present in 43% of patients
with alteration in coagulation test. There are
many explanations to haemostatic alterations in
DHF /DSS such as a low production of coagula-
tion factors due to liver involvement, imbalance
between coagulation and fibrinolysis and an
immune response against platelets and endo-
thelium which are correlated to disease severity.
Myocarditis an unusual complication has been
described as a mild bradycardia in late phase
with few clinical signs and edema and hemo-
rrhage in autopsies(14). However, in the last two
years a severe form of myocarditis associated to
dengue virus has been reported in our region
with a fatality case of fulminant myocarditis(15, 16).
In this study a 23% of patient had rhythm
changes suggestive of myocarditis however it
lacks of another test to confirm this diagnosis.
To extent the analysis of the myocarditis, we
recently show at the first time, the direct infection
of human muscle cardiac cells by dengue virus
in vivo(17).
It has been suggested that cytokines and
chemical mediators play a role in the patho-
genesis of DHF /DSS. One of the cells res-
ponsible of cytokine production is T lymphocyte
that releases several cytokines including IFNγ,
IL-2, IL-4, IL-5, IL-6, IL-10, and lymphotoxin.
Monocytes/macrophages also produce TNFα,
IL-1, IL-1b, IL-6, and PAF(18), furthermore, some
reports have demonstrated the production of
cytokines or chemokines after in vitro DV
infection of different types of cells, including
endothelial cells(19,20), blood monocytes(21), liver
Kuppfer cells(22), mast cell/basophil line(23,24)
thus, cytokine responses is proportional to the
infected cell mass(25).
The studies cytokines functions in dengue
infection come from in vitro assays with specific
cell bulk. In the clinical context it results difficult
due to the complexity of cytokines network
because they can activate cells synergistically or
antagonistically and the net outcome will depend
on the balance between various cytokine actions.
It is clear that each cytokine pattern belong to a
specific T helper response that will depend on
antigen challenge. In dengue virus, studies show
a Th1 pattern (IFNγ –IL2) in early phase of
diseases and shift toward a Th2 response (IL4,
IL5, IL6, IL10, IL13) in the late phase(26). From
culture supernatants on infected cells, cytokines
recovered on the first day post-infection were
human cytotoxic factor (hCF), TNFα, IL-2 and
IL-6; their levels reached a peak on the second
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de Janeiro, Brazil is described in one patient with
serum level of 900 pg/ml TNFα(30). Experimen-
tal studies with anti TNFα based on the pre-ter-
minal TNFα peak seen in lethal dengue model,
found that animals treated with anti-TNFα
serum have a better survive(31). Patients from the
study showed very high serum levels of TNFα
in dengue hemorrhagic patient compared to
healthy patients. This finding can explain the
high proportion of DHF vs DF seen in children
from our region due to the important role of
TNFα in endothelium activation leading to plas-
ma leakage and bleeding forms.
The IL-6 plays also a central role in pathogenesis
of dengue due to its wide range of immune and
hematopoietic activities and also its potential
ability to induce the acute phase response,
induction of terminal differentiation of B cells
and activation of T cells. Different studies des-
cribed IL-6 increased after dengue virus
infection. Some studies show a correlation
between severity of illness and IL-6 levels. One
study in 186 children showed IL6 levels
correlated with shock in DHF, they found
higher plasma levels of IL-6 in the shock group
than in no shock group (p = 0.05) however,
although IL-6 levels were somewhat higher in
the DHF patients than in the DF patients, this
did not reach statistical significance. Another
study in 24 patients with DHF (4 to 75 years
old) showed levels of IL-6 significantly elevated
in DHF/DSS patients but not in DF patients,
compared to normal controls or patients with
other febrile illness(32). In contrast with these
studies, we found higher levels in DHF patients
than controls but this cytokine was higher in
the group without shock similar to a prospective
study(25), in which IL-6 levels tended to be lower
in patients in shock than those not in shock.
This finding could be explaining by the
cytokines kinetic where the highest levels of IL-6
are seen around 3th day and decline thereafter.
In this study patients were enrolled around
sixth day when the clearance of this cytokine
has begin.
IFNγ could have a double function, one is the
viral clearance thanks to T cells and DC acti-
vation, and by the other hand could facilitate
the antibody-depending enhancement (ADE)
due to a up-regulate of the expression of FCy
receptors. The increased number of dengue vi-
rus-infected monocytes/macrophages results in
an elevation of T-cell activation, which results
in the release of high levels of cytokines and
chemical mediators with an increase in vascular
permeability, plasma leakage, shock, and
malfunction of the coagulation system(18,33)
which coincide with our finding of higher levels
in the group with shock (Figure 1).
It has been show that IFNγ was able to decrease
the infection and virus titer in dendritic cells at
48 h(10). This is supported by clinical studies
which show an elevation of IFNγ in early phase
on or before the day of defervescence, coinciding
with disappearance of viraemia(34).
When serum levels of cytokines measured in
children from the study are compared to other
endemic regions for dengue we found a very
high levels of TNFα and IL-6 (Figure 1). This fact
can be explaining by an individual variation in
HLA context(25,35) that could be contributing to a
more severity, shock and complicated forms seen
in our patients. Consistent with that interpre-
tation, a recent study in two ethnic colombian
groups (afro-colombian and mestizos) show
important and significant differences between
the cytokine pattern present in patients with
dengue fiver and DHF(36).
However we could not demonstrated correla-
tion between cytokines and shock, myocarditis,
hepatitis and bleeding forms probably to be
measured at specific point of time (sixth day)
where the kinetic behavior of cytokines could
not be seen.
In conclusion, at sixth day of disease our patients
show a still a high proinflammatory and Th1
response which contribute to understanding of
the disease and can support the hypothesis
of benefit with immunomodulatory therapy in
these patients.
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